4//SEC Filing
Francois Cedric 4
Accession 0001193125-25-192797
CIK 0001492422other
Filed
Aug 28, 8:00 PM ET
Accepted
Aug 29, 4:19 PM ET
Size
11.3 KB
Accession
0001193125-25-192797
Insider Transaction Report
Form 4
Francois Cedric
DirectorChief Executive Officer
Transactions
- Sale
Common Stock
2025-08-27$28.19/sh−175,037$4,934,293→ 357,909 total(indirect: By Trust) - Sale
Common Stock
2025-08-28$28.39/sh−49,963$1,418,450→ 307,946 total(indirect: By Trust)
Holdings
- 331,605
Common Stock
- 300,000(indirect: By Trust)
Common Stock
- 472,065(indirect: By Trust)
Common Stock
- 234,411(indirect: By Trust)
Common Stock
Footnotes (6)
- [F1]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.78 - $28.49, inclusive. The reporting person hereby undertakes to provide, upon request, to the staff of the Securities and Exchange Commission, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (3) to this Form 4.
- [F2]The securities are held by The Cedric Francois Irrevocable Trust of 2023 - 2. William V. A. Zorn is the trustee of The Cedric Francois Irrevocable Trust of 2023 - 2. The reporting person disclaims beneficial ownership over the shares held by The Cedric Francois Irrevocable Trust of 2023 - 2 except to the extent of his pecuniary interest therein.
- [F3]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.14 - $28.68, inclusive.
- [F4]The securities are held by The Cedric Francois Irrevocable Trust of 2023. William V. A. Zorn is the trustee of The Cedric Francois Irrevocable Trust of 2023. The reporting person disclaims beneficial ownership over the shares held by The Cedric Francois Irrevocable Trust of 2023 except to the extent of his pecuniary interest therein.
- [F5]The securities are held by The Francois Grossi Trust, for which Juliana Grossi, the spouse of the reporting person, serves as trustee. The reporting person disclaims beneficial ownership over the shares held by the Francois Grossi Trust except to the extent of his pecuniary interest therein.
- [F6]The securities are held by The Francois-DuBois Educational Trust, for which the Fiduciary Trust Company of New England serves as trustee. The reporting person disclaims beneficial ownership over the shares held by The Francois-DuBois Educational Trust except to the extent of his pecuniary interest therein.
Documents
Issuer
Apellis Pharmaceuticals, Inc.
CIK 0001492422
Entity typeother
Related Parties
1- filerCIK 0001658080
Filing Metadata
- Form type
- 4
- Filed
- Aug 28, 8:00 PM ET
- Accepted
- Aug 29, 4:19 PM ET
- Size
- 11.3 KB